HAE
HAEMONETICS CORP
Key Financials
Operating Income
$221.8M
↑ 34.5%
Gross Profit
$749.0M
↑ 8.3%
Net Income
$167.7M
↑ 42.6%
Revenue
$1.4B
↑ 4.0%
EPS (Diluted)
$3.31
↑ 44.5%
Shareholders' Equity
$820.8M
↓ 14.5%
Total Assets
$2.5B
↑ 11.6%
Cash & Equivalents
$306.8M
↑ 71.6%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | HAE |
| Company Name | HAEMONETICS CORP |
| CIK | 313143 |
| SIC Code | 3841 |
| SIC Description | Surgical & Medical Instruments & Apparatus |
| Entity Type | operating |
| Fiscal Year End | 0328 |
| State of Incorporation | MA |
| Phone | 7818487100 |